drugset / Trial / NCT04665791
A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults
Completed
55 enrolled
Center for Vaccine Development - Mali
Public Health England · collabUniversity College, London · collabUniversity of Maryland · collabUniversity of Oxford · collabUniversity of Southampton · collab
NaSingle-groupOpen-labelBasic science
Summary
This study is part of a series of projects to improve protection against meningitis. Previously, researchers have given nose drops containing N. lactamica to over 400 volunteers and shown that many of them become colonised with N. lactamica without causing any illness or disease. This has previously been shown to prevent people from becoming colonised with N. meningitidis which can cause meningitis. This study aims to give nose drops containing N. lactamica to healthy adults in Mali, to see if they become safely colonised. In the future the study team would like to find out how N.lactamica helps children resist N.meningitidis, and develop new vaccines that exploit that mechanism.
Timeline
- Start
- 2021-03-02
- Primary completion
- 2021-10-10
- Completion
- 2023-06-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neisseria lactamica | Other / unclassified | 100000 unknown | — |
| Subject | Neisseria lactamica | Other / unclassified | 1e+07 unknown | — |